Current Status of Five Different Regimens for Empiric First-Line Helicobacter pylori Eradication in Turkey

Publisher： Karger

E-ISSN： 1421-9867|92|2|55-59

ISSN： 0012-2823

Source： Digestion, Vol.92, Iss.2, 2015-07, pp. : 55-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis

By Xiao Shu-Ping   Gu Min   Zhang Guo-Xin  

Scandinavian Journal of Gastroenterology, Vol. 49, Iss. 5, 2014-05 ,pp. : 528-538

Informa Healthcare

Access to resources Recommend Favorite

Bismuth-Based First-Line Therapy for Helicobacter pylori Eradication in Type 2 Diabetes Mellitus Patients

By  

Digestion, Vol. 82, Iss. 1, 2010-03 ,pp. : 47-53

Karger

Access to resources Recommend Favorite

Comparison of Levofloxacin- and Moxifloxacin-Based Triple Therapies with Standard Treatment in Eradication of Helicobacter Pylori as First-Line Therapy

By  

Digestion, Vol. 90, Iss. 4, 2014-12 ,pp. : 261-264

Karger

Access to resources Recommend Favorite

Eradication of Helicobacter pylori: Are Rifaximin-Based Regimens Effective?

By  

Digestion, Vol. 73, Iss. 1, 2006-02 ,pp. : 129-135

Karger

Access to resources Recommend Favorite

Rifaximin-Based Regimens for Eradication of Helicobacter pylori: A Pilot Study

By  

Digestive Diseases, Vol. 24, Iss. 1-2, 2006-05 ,pp. : 195-200

Karger

Access to resources Recommend Favorite